Owner ViRexx Medical Corp.

Inventors Tyrrell, Lorne; Ma, Allan; Noujaim, Antoine; Wang, Dakan; Motyka, Bruce; George, Rajan

Agent Pizzeys

Pub. Number AU-A-2006301846

PCT Pub. Number WO2007/041861

Priority 60/726,701 13.10.05 US

Filing date 13 October 2006

Wipo publication date 19 April 2007

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

A61K 39/29 (2006.01) Medicinal preparations containing antigens or antibodies - Hepatitis virus

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 14/18 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/51 (2006.01) Mutation or genetic engineering - Hepatitis viruses

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione